BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19129688)

  • 1. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
    Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
    Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.
    Azami Y; Tsuyama N; Abe Y; Sugai-Takahashi M; Kudo KI; Ota A; Sivasundaram K; Muramatsu M; Shigemura T; Sasatani M; Hashimoto Y; Saji S; Kamiya K; Hanamura I; Ikezoe T; Onodera M; Sakai A
    Sci Rep; 2021 Mar; 11(1):5216. PubMed ID: 33664418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic multiple myeloma resembling dysplastic megakaryocytes.
    Xie W; Tang G; Li S; Yin CC; Xu J
    Clin Case Rep; 2020 Mar; 8(3):568-569. PubMed ID: 32185061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion.
    Alencar RN; Martinez GA; Cordeiro MG; Velloso EDRP
    Hematol Transfus Cell Ther; 2023; 45(4):495-498. PubMed ID: 34862156
    [No Abstract]   [Full Text] [Related]  

  • 5. A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy.
    Hammani A; Doghmi O; Allaoui M; Ababou M; Mahtat EM; El Maaroufi H; Doghmi K
    Cureus; 2024 Jan; 16(1):e52622. PubMed ID: 38374866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy.
    Krishnan N; Price R; Kotchetkov R
    Front Oncol; 2023; 13():1213942. PubMed ID: 37361582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report.
    Kimura H; Furukawa M; Mori H; Shiga Y; Asai J; Satoh K; Kai T
    Clin Case Rep; 2022 Nov; 10(11):e6614. PubMed ID: 36415705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Concomitant Diagnosis of Plasma Cell Leukemia in Patient With JAK2 Positive Myeloproliferative Neoplasm.
    Kurian CJ; Thomas C; Houtmann S; Klumpp T; Binder AF
    Front Oncol; 2020; 10():1497. PubMed ID: 32974181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential Thrombocythaemia with Concomitant Waldenström Macroglobulinaemia: Case Report and Literature Review.
    Lu N; Neoh CL; Ruan Z; Zhao L; Ying L; Zhang X; Chen S; Xu L
    Onco Targets Ther; 2020; 13():3431-3435. PubMed ID: 32425546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extranodal marginal zone lymphoma of the uterine cervix with concomitant copy number gains of the
    Takimoto T; Maegawa S; Tatsumi H; Nagoshi H; Chinen Y; Shimura Y; Kobayashi T; Horiike S; Nakamura S; Kitawaki J; Kuroda J; Taniwaki M
    Oncol Lett; 2017 May; 13(5):3641-3645. PubMed ID: 28521466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis.
    Niscola P; Catalano G; Fratoni S; Scaramucci L; de Fabritiis P; Caravita T
    Blood Res; 2013 Sep; 48(3):228-30. PubMed ID: 24086946
    [No Abstract]   [Full Text] [Related]  

  • 12. The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report.
    Leković D; Gotić M; Mitrović O; Radojković M; Bila J; Dencic-Fekete M; Kraguljac-Kurtović N; Peruničić-Jovanović M; Cokić V
    J Med Case Rep; 2013 Sep; 7():224. PubMed ID: 24025541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
    Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
    Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
    Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
    Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
    Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transition to aggressive phase in a multiple myeloma patient with IgH/CCND1 translocation and diffuse osteosclerotic lesions].
    Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2016 Apr; 57(4):483-8. PubMed ID: 27169455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/CCND1 gene translocation coexist, but originate from separate clones.
    Kuroda J; Matsumoto Y; Tanaka R; Kurita K; Kobayashi T; Shimizu D; Kimura S; Ashihara E; Horiike S; Shimazaki C; Taniwaki M
    Acta Haematol; 2008; 120(3):177-81. PubMed ID: 19129688
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.